Physician Connect™ Syndicated Studies

Optimize Sales and Marketing Efforts with Physician Key Influencer Data

Identifying and understanding key influencers and their networks is critical to increasing the success of pharmaceutical product adoption. Cegedim’s Physician Connect™ Syndicated uses a methodology that identifies the hidden influencers and reveals the interaction with the clinicians they influence. Delivering over 500 studies and covering over 80 countries, Physician Connect™ has the capability to discover influencers on international, national, regional, and local levels.

The Approach
Physician Connect™ Syndicated uses a bottom up approach to identify key influencers and their network:

• A large number of relevant physicians are interviewed using web and paper based survey
• Data is gathered to discover who influences the way physicians treat their patients and the type of influence associated
• Advanced reporting platform offers detailed profile of influenced physicians
• Results help identify, define, and understand multiple network links, understand the communities of practice, and uncover and quantify new market potential
• Complete analysis of network universes and the ability to use Cegedim’s tactical marketing options
• Process is entirely compliant with local data privacy laws

With Physician Connect you can:

• Identify current and future key influencers for your product in all regions
• Find the thought leaders in group practices
• Effectively uncover the local drivers of prescribing activity
• Understand the networks that accelerate adoption within your therapeutic category
• Develop targeted messages to encourage advocacy for your brand
• Recruit and train speakers
• Identify advisory board members and clinical trials investigators
• Develop and/or reinforce product strategy
• Understand the dynamics in niche markets

Multi-Country Studies
These high-value international Physician Connect studies are available:

• The Oncology study I – Lung Cancer, Colorectal Cancer and Prostate Cancer
• The Oncology study II – Breast Cancer, Ovarian Cancer, Renal Cell Carcinoma and Bladder
• The Oncology study III – Non Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia, Chronic Myelocytic Leukaemia, Multiple myeloma, Myelodysplastic syndrome

Discover Influencer Insights Such as:
- Rising stars among influencers
- Preferred channels of communications
- Payer advisory boards
- Centers of Excellence
- Referral patterns
- Treatment algorithms
- Patient population from a KOL network

Download this resource:
Physician Connect Syndicated product fact sheet